Genzyme Ireland provide insight into physical chemistry considerations for the Lyophilisation of Biopharmaceuticals | 7-8 July 2014

Sean Cullen, Development Scientist, Genzyme Ireland discusses the latest optimisation and validation methods in the freeze-drying field at SMi's second annual Lyophilisation: Pharmaceuticals and Biopharmaceuticals Conference, 7-8 July, London, UK.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
2nd annual Lyophilisation conference

Lyophilisation 2014: Pharmaceuticals and Biopharmaceuticals

Lyophilisation 2014 will provide a mix of case study led presentations, panel debates and keynote addresses that have been tailored to an audience of professionals.

London, Southwark (PRWEB UK) 24 May 2014

Join SMi's second annual Lyophilisation conference on 7-8 July 2014, London. This event will provide an update on best practices in lyophilisation and examine the latest techniques and industry case studies. With a workshop and sessions led by experts, you will gain an array of tools and tips to deliver the best outcome for your organisation.

Genzyme Ireland will be speaking at this year's Lyophilisation conference to provide insights into the role and impact of physical chemistry during freeze-drying processes of biopharmaceuticals.

Highlights from the presentation entitled, Physical Chemistry Considerations for Lyophilisation of Biopharmaceuticals, will include:

  • The role and impact of physical chemistry on the lyophilisation process, stability and structure of biopharmaceuticals
  • The impact of lyophilisation process parameters on excipient state - crystalline versus amorphous and the methods of stabilisation by amorphous excipients
  • Stresses experienced by proteins during the lyophilisation process
  • Correlating moisture and the glass transition temperature during secondary drying to assess product stability

Lyophilisation 2014 will provide a mix of case study led presentations, panel debates and keynote addresses that have been tailored to an audience of professionals involved in PAT implementation, mathematical modelling, design and scale-up, to optimising and validating freeze drying life cycles. The above is just a snap shot of what will be covered at the event. To download a brochure, visit http://www.lyophilisation-conference.com.

Some of the confirmed attendees so far include: Boehringer Ingelheim, Allembis, Norgine, Explicat Pharma, MedImmune, Novo Nordisk, GlaxoSmithKline, Ellab, Ipsen, Ghent University, GEA Pharma Systems, GEA Process Engineering, Bavarian Nordic, Imperial College London, Chr. Hansen, LFB Technologies, University of Sao Paulo, plus many more.

For more information and full programme details, please visit:

Lyophilisation 2014: Pharmaceuticals & Biopharmaceuticals
7-8 July, 2014
Marriott Regents Park Hotel, London, UK
http://www.lyophilisation-conference.com

About SMi Group

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries.

We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries.

More information can be found at http://www.smi-online.co.uk.


Contact

Attachments